Abstract
Nucleotide-sugar transporters (NSTs) transport nucleotide-sugar conjugates into the Golgi lumen where they are then used in the synthesis of glycans. We previously reported crystal structures of a mammalian NST, the CMP-sialic acid transporter (CST) (Ahuja and Whorton 2019). These structures elucidated many aspects of substrate recognition, selectivity, and transport; however, one fundamental unaddressed question is how the transport activity of NSTs might be physiologically regulated as a means to produce the vast diversity of observed glycan structures. Here, we describe the discovery that an endogenous methylated form of cytidine monophosphate (m5CMP) binds and inhibits CST. The presence of m5CMP in cells results from the degradation of RNA that has had its cytosine bases post-transcriptionally methylated through epigenetic processes. Therefore, this work not only demonstrates that m5CMP represents a novel physiological regulator of CST, but it also establishes a link between epigenetic control of gene expression and regulation of glycosylation.
Funder
National Institute of General Medical Sciences
Publisher
Public Library of Science (PLoS)
Reference37 articles.
1. Targeting glycosylation as a therapeutic approach;RA Dwek;Nature reviews Drug discovery,2002
2. Vertebrate protein glycosylation: diversity, synthesis and function;KW Moremen;Nature reviews Molecular cell biology,2012
3. Glycosylation in cellular mechanisms of health and disease;K Ohtsubo;Cell,2006
4. Structure and function of nucleotide sugar transporters: Current progress;B Hadley;Computational and structural biotechnology journal,2014
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献